Psychotropic drug use in the Norwegian general population in 2005: data from the Norwegian Prescription Database
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Purpose: To analyse psychotropic drug utilisation patterns in the general population of Norway in 2005. Methods: Data on 4 163 045 prescriptions of psychotropic drugs dispensed at all pharmacies in Norway during 2005 were extracted from The Norwegian Prescription Database (NorPD), including antipsychotics (ATC‐code N05A), anxiolytics (N05B), hypnotics (N05C) and antidepressants (N06A). This information was merged with data concerning the 3857 general practitioners (GPs) from the Norwegian Regular GP Scheme. Results: A total of 705 230 individuals, or 15.3% of the general population, received at least one prescription of a psychotropic drug. The figures for the four therapeutic subgroups were 2.4% for antipsychotics, 6.2% for anxiolytics, 7.9% for hypnotics and 6.0% for antidepressants, respectively. For all subgroups, prevalence was higher among women than among men, and increased steadily by patients' age. The mean annual drug volume per patient was highest among persons aged 40–59 years, except for hypnotics where it continued to increase with age. GPs prescribed 80% of overall psychotropic drug volume, psychiatrists 5%, and other prescribers 15%. The proportion of the drugs issued by the three prescriber groups differed with the patients' age group. While children and adolescents received a relatively large share from paediatricians and child and adolescent psychiatrists, adults mostly got their prescriptions from GPs. Conclusions: The majority of psychotropic drugs were prescribed by GPs. Overall drug use increased significantly, and psychiatrists' contribution decreased significantly with patients' age. The quality of pharmacological treatment for mental health problems of the general and aging population therefore relies mainly on the GPs. Copyright © 2009 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alonso, J., Angermeyer, M. C., & Lépine, J. P. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00325.x · Cited by 758
Sivertsen, B., Omvik, S., Pallesen, S., Bjorvatn, B., Havik, O. E., Kvale, G., Nielsen, G. H., & Nordhus, I. H. (2006) · JAMA · doi:10.1001/jama.295.24.2851 · Cited by 589
Ohayon, M. M., & Lader, M. H. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0912 · Cited by 271
Cited by
Benzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Torres-Bondia, F., de Batlle, J., Galván, L., Buti, M., Barbé, F., & Piñol-Ripoll, G. (2020) · BMC Public Health · doi:10.1186/s12889-020-08984-z · Cited by 69
Managing Mental Health Problems Among Immigrant Women Attending Primary Health Care Services
Straiton, M. L., Powell, K., Reneflot, A., & Diaz, E. (2016) · Health Care for Women International · doi:10.1080/07399332.2015.1077844 · Cited by 26
Lornstad, M. T., Aarøen, M., Bergh, S., Benth, J. Š., & Helvik, A.-S. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1126-y · Cited by 24
Sundseth, A. C., Gjelstad, S., Straand, J., & Rosvold, E. O. (2018) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2018.1459164 · Cited by 19
“In Norway in year 2005, 85% of hypnotics and anxiolytics to patients 70 years were issued by GPs [13,17].”
Background
Metadata
- Authors
- Kjosavik, S. R., Ruths, S., & Hunskaar, S.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2009-04-28
- Volume
- 18
- Issue
- 7
- Pages
- 572-578
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2023001725
- Cited by
- 56
- References
- 3
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.